$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Upadatinib and deuterated colexitinib are two large molecule drugs for the treatment of psoriatic arthritis.
2026-02-01 22:25:32
Check Details
Full analysis of the instructions for Apremilast/Apremilast tablets and a comprehensive medication guide!
2026-02-01 22:25:32
Check Details
What is the market price of a box of Valganciclovir?
2026-02-01 22:25:32
Check Details
Once you take aprexitentan, can you stop it for life? Medication cycle and precautions
2026-02-01 22:25:32
Check Details
In T2D, switching to tilsiparatide/tilpotide shows greater benefit than escalating dulaglutide
2026-02-01 22:25:32
Check Details
The current status of pitobrutinib/pitubrutinib being launched in China is revealed!
2026-02-01 22:25:32
Check Details
Important information in the instructions for avatrombopag and what patients should pay attention to
2026-02-01 22:25:32
Check Details
The role and efficacy of giritinib: analysis of indications and treatment principles
2026-02-01 22:25:32
Check Details
Midostaurin: a specific drug for the treatment of blood diseases, detailed explanation of efficacy and indications
2026-02-01 22:25:32
Check Details
Cabergoline Price Revealed: How much does a box cost?
2026-02-01 22:25:32
Check Details
Molotinib/mometinib, as a jak inhibitor, is the first generation of targeted drugs
2026-02-01 22:25:32
Check Details
What are the side effects of long-term use of Bitovil/Bikonprenol tablets? How patients respond scientifically
2026-02-01 22:25:32
Check Details
1
2
...
1451
1452
1453
1454
1455
1456
1457
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
2
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
3
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
4
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
5
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
6
Cabergoline Medication Guide: Contraindications, Treatment Costs, and Safety Monitoring Essentials
7
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
8
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia
9
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
10
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
11
Filgotinib: Mechanism of Action and Clinical Applications Explained
12
Lapatinib: Proper Administration Guide and Key Precautions